The ESR1 and GPX1 gene expression level in human malignant and non-malignant breast tissues.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsKról, Magdalena B
MetadataShow full item record
AbstractThe aim of this study was to establish whether the gene expression of estrogen receptor alpha (encoded by ESR1) correlates with the expression of glutathione peroxidase 1 (encoded by GPX1) in the tumor and adjacent tumor-free breast tissue, and whether this correlation is affected by breast cancer. Such relationships may give further insights into breast cancer pathology with respect to the status of estrogen receptor.
We used the quantitative real-time PCR technique to analyze differences in the expression levels of the ESR1 and GPX1 genes in paired malignant and non-malignant tissues from breast cancer patients.
ESR1 and GPX1 expression levels were found to be significantly down-regulated by 14.7% and 7.4% (respectively) in the tumorous breast tissue when compared to the non-malignant one. Down-regulation of these genes was independent of the tumor histopathology classification and clinicopathological factors, while the ESR1 mRNA level was reduced with increasing tumor grade (G1: 103% vs. G2: 85.8% vs. G3: 84.5%; p<0.05). In the non-malignant and malignant breast tissues, the expression levels of ESR1 and GPX1 were significantly correlated with each other (Rs=0.450 and Rs=0.360; respectively).
Our data suggest that down-regulation of ESR1 and GPX1 was independent of clinicopathological factors. Down-regulation of ESR1 gene expression was enhanced by the development of the disease. Moreover, GPX1 and ESR1 gene expression was interdependent in the malignant breast tissue and further work is needed to determine the mechanism underlying this relationship.
CitationActa Biochim. Pol.2018 Vol. 65
JournalActa Biochimica Polonica
SponsorsThis study was funded by the Polish Ministry of Science and Higher Education as the internal grant of the Nofer Institute of Occupational Medicine (grant number: IMP1.12/2012-2014)
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as Archived with thanks to Acta biochimica Polonica
- Neo-tanshinlactone selectively inhibits the proliferation of estrogen receptor positive breast cancer cells through transcriptional down-regulation of estrogen receptor alpha.
- Authors: Lin W, Huang J, Liao X, Yuan Z, Feng S, Xie Y, Ma W
- Issue date: 2016 Sep
- Clinical and Biological Significance of <i>ESR1</i> Gene Alteration and Estrogen Receptors Isoforms Expression in Breast Cancer Patients.
- Authors: Nagel A, Szade J, Iliszko M, Elzanowska J, Welnicka-Jaskiewicz M, Skokowski J, Stasilojc G, Bigda J, Sadej R, Zaczek A, Markiewicz A
- Issue date: 2019 Apr 16
- Relationships of ESR1 and XBP1 expression in human breast carcinoma and stromal cells isolated by laser capture microdissection compared to intact breast cancer tissue.
- Authors: Andres SA, Wittliff JL
- Issue date: 2011 Oct
- Estrogen receptor alpha gene ESR1 amplification may predict endocrine therapy responsiveness in breast cancer patients.
- Authors: Tomita S, Zhang Z, Nakano M, Ibusuki M, Kawazoe T, Yamamoto Y, Iwase H
- Issue date: 2009 Jun
- Prognostic significance of glutathione peroxidase 1 (GPX1) down-regulation and correlation with aberrant promoter methylation in human gastric cancer.
- Authors: Min SY, Kim HS, Jung EJ, Jung EJ, Jee CD, Kim WH
- Issue date: 2012 Aug